Objectives We evaluated short-term results of transcatheter closure of secundum atrial
septal defects (ASD) with the Amplatzer septal occluder (ASO) in adults. Study design The …

Objectives: To evaluate the efficacy and safety of transcatheter closure of atrial septal
defects (ASD) in patients over 70 years of age. Background: Transcatheter closure of ASD is …

Aims: Transcatheter closure of the secundum type atrial septal defect (ASD) is widely
practised. We report complications and efficacy of percutaneous ASD closure in adults using …

OBJECTIVE: This study reports the procedural, short and medium term outcomes in patients
receiving multiple implants for device closure of secundum atrial septal defects (ASD) …

Background The Occlutech Figulla ASD device series (OFSO) shows an improved device
design for interventional ASD closure, larger follow‐up series are missing. Methods We …

OBJECTIVES. The goals were to assess the frequency of spontaneous closure of isolated
secundum atrial septal defect in children and to identify predictors of spontaneous atrial …

BACKGROUND: Percutaneous closure of atrial septal defect (ASD) is a valid alternative to
surgical approach. Current device has significantly improved the success rate also in …

We reviewed our experience using the Amplatzer septal occluder (AGA Medical, Golden
Valley, MN, USA) to close large, secundum-type atrial septal defects (ASDs) in children …

Background Transcatheter (TC) atrial septal defect (ASD) closure has been the mainstay of
therapy for secundum-type ASDs for over 20 years. Aims This nationwide cohort evaluated …

Background: Secundum atrial septal defect (ASD) is a common congenital heart defect in
adults. If untreated, ASD leads to right ventricular (RV) failure, atrial arrhythmias, and …